CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY

Silvio Danese  1     William Sandborn  2     Edward V. Loftus Jr.  3     Stephen B Hanauer  4     Stefan Schreiber  5     Laurent Peyrin-Biroulet  6     Remo Panaccione     Julian Pan├ęs     Filip Baert     Jean-Frederic Colombel     Marc Ferrante     Edouard Louis     Alessandro Armuzzi     Sasikiran Goteti     John Liu     Nael M. Mostafa     Thao Doan     Joel Petersson     Anne M. Robinson    
1 Humanitas Research Hospital,Rozzano,Italy
2 University of California San Diego,La Jolla,United States
3 Mayo Clinic,Rochester,United States
4 Feinberg School of Medicine, Northwestern University,Chicago,United States
5 Universit├Ąt Kiel UKSH,Kiel,Germany
6 Nancy University Hospital Inserm U954 Department of Hepato-Gastroenterology,Vandoeuvr

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing